Resveratrol and quercetin down-regulate tissue factor expression by human stimulated vascular cells

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 5, 2003, Pages 1089-1095

  Santo, A D ^a   Mezzetti, A ^a   Napoleone, E ^a   Tommaso, R D ^a   Donati, M B ^b   De Gaetano, G ^b   Lorenzet, R ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Quercetin; Resveratrol; Tissue factor; Vascular cells

Indexed keywords

EID: 7244234945     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00217.x     Document Type: Article

References (52)

1. Rimm EB, Giovannucci EL, Willett WC, Colditz GA, Ascherio A, Rosner B, StampferMJ. Prospective study of alcohol consumption and risk of coronary disease in men. Lancet 1991; 338: 464-8.
2. Renaud SC, Gueguen R, Schenker J, d'HouraudA. Alcoholandmortalityin middle-aged men from Eastern France. Epidemiology 1998; 9: 184-8.
3. Renaud S, de Lorgeril M. Wine, alcohol, platelets and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-6.
4. Rotondo S, de Gaetano G. Protection from cardiovascular disease by wine and its derived products. Epidemiological evidence and biological mechanisms. World Rev Nutr Diet 2000; 87: 90-113.
5. Di Castelnuovo A, Rotondo S, Iacoviello L, Donati MB, De Gaetano G. Meta-analysis of wine and beer consumption in relation to vascular risk. Circulation 2002; 105: 2836-44.
6. Subbaramaiah K, Chung WJ, Michaluart P, Telang N, Tanabe T, Inoue H, Jang M, Pezzuto JM, Dannenberg AJ. Resveratrol inhibits cyclo-oxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J Biol Chem 1998; 273: 21875-82.
7. Frankel EN, Waterhouse AL, Kinsella JE. Inhibition of human LDL oxidation by resveratrol. Lancet 1993; 341: 1103-4.
8. Holmes-McNary M, Baldwin AS Jr. Chemopreventive properties of ira/w-resveratrol are associated with inhibition of activation of the IkappaB kinase. Cancer Res 2000; 60: 3477-83.
9. Abou-Agag LH, Torres JA, Tabengwa EM, Benza RL, Shows SR, Aikens MA, Grenett HE, Booyse FM. Polyphenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells. Alcohol Clin Exp Res 2001; 25: 155-62.
10. Rotondo S, Rajtar G, Manarini S, Celardo A, Rotillo D, de Gaetano G, Evangelista V, Cerletti C. Effect of trans-resveratrol, a natural poly-phenolic compound, on human polymorphonuclear leukocyte function. BrJ Pharmacol 1998; 123: 1691-9.
11. Rotondo S, Rotilio D, Cerletti C, de Gaetano G. Red wine, aspirin and platelet function. Thromb Haemost 1996; 76: 818-9.
12. Pace-Asciak CR, Hahn S, Diamandis EP, Soleas G, Goldberg DM. The red wine phenolics irans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: implications for protection against coronary heart disease. Cli Chim Ada 1995; 235: 207-19.
13. Gerritsen ME, Carley WW, Ranges GE, Shen CP, Phan SA, Ligon GF, Perry GA. Flavonoids inhibit cytokine-induced endothelial cell adhe sion protein gene expression. Am J Pathol 1995; 147: 278-92.
14. Kobuchi H, Roy S, Sen CK, Nguyen HG, Packer L. Quercetin inhibits inducible ICAM-1 expression in human endothelial cells through the JNK pathway. Am J Physiol 1999; 277: C403-11.
15. Nemerson Y. Tissue factor and hemostasis. Blood 1988; 71: 1-8.
16. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-97.
17. Semeraro N, Biondi A, Lorenzet R, Locati D, Mantovani A, Donati MB. Direct induction of tissue factor synthesis by endotoxin in human macrophages from diverse anatomical sites. Immunology 1983; 50: 529-35.
18. Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Semeraro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893-6.
19. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr. Recombinant tumor necrosis factor induces procoagulant ac tivity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Nad Acad Sci USA 1986; 83: 4533-7.
20. Oeth P, Parry GCN, Mackman N. Regulation of the tissue factor gene in human monocytic cells. Role of AP-1, NF-KB/Rel, and Spl proteins in uninduced and lipopolysaccharide-induced expression. Arterioscler Thromb Vase Biol 1997; 17: 365-74.
21. Read MA, Whitkey MZ, Williams AJ, Collins T. NF-kappa B and I kappa Ba: an inducible regulatory system in endothelial activation. J Exp Med 1994; 179: 503-12.
22. Annex BH, Denning SM, Channon KM, Sketch MH Jr, Stack RS, Morrissey JH, Peters KG. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes. Circulation 1995; 91: 619-22.
23. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation 1996; 94: 1226-32.
24. Ardissino D, Merlini PA, Ariens R, Coppola R, Bramucci E, Mannucci PM. Tissue-factor antigen and activity in human coronary atherosclero tic plaques. Lancet 1997; 349: 769-71.
25. Napoleone E, Di Santo A, Lorenzet R. Monocytes upregulate endothe lial cell expression of tissue factor: a role for cell-cell contact and cross talk. Blood 1997; 89: 541-9.
26. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B. P-selectin induces the expression of tissue factor on monocytes. Proc Nad Acad Sci USA 1994; 91: 8767-71.
27. Napoleone E, Di Santo A, Camera M, Tremoli E, Lorenzet R. Angio-tensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circ Res 2000; 86: 139-43.
28. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME. Novel inhibitors of cytokine-induced ItcBa phosphoryla-tion and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997; 272: 21096-103.
29. Pendurthi UR, Williams JT, Rao VM. Resveratrol, a polyphenolic compound found in wine, inhibits tissue factor expression in vascular cells. A possible mechanism for the cardiovascular benefits associated with moderate consumption of wine. Arterioscler Thromb Vase Biol 1999; 19: 419-26.
30. Ardissino D, Merlini PA, Bauer KA, Bramucci E, Ferrario M, Coppola R, Fetiveau R, Lucreziotti S, Rosenberg RD, Mannucci PM. Thrombo-genic potential of human coronary atherosclerotic plaques. Blood 2001; 98: 2726-9.
31. Badimon L. Atherosclerosis and thrombosis: lessons from animal models. Thromb Haemost 2001; 86: 356-65.
32. Hajra L, Evans AI, Chen M, Hyduk SJ, Collins T, Cybulsky MI. The NF-kappa B signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation. Proc Nad Acad Sci USA 2000; 97: 9052-7.
33. Ritchie ME. Nuclear factor-KB is selectively and markedly activated in humans with unstable angina pectoris. Circulation 1998; 98: 1707-13.
34. De Martin R, Hoeth M, Hofer-Warbinek R, Schmid JA. The transcrip tion factor NF-kappa B and the regulation of vascular cell function. Arterioscler Thromb Vase Biol 2000; 20: e83-8.
35. Sawa Y, Morishita R, Suzuki K, Kagisaki K, Kaneda Y, Maeda K, Kadoba K, Matsuda H. A novel strategy for myocardial protection using in vivo transfection of cis element 'decoy' against NFKB binding site. Evidence for a role of NFKB in ischemia-reperfusion injury. Circulation 1997; 96 (Suppl. II): 280-5.
36. Pendurthi UR, Meng F, Mackman N, Rao LV. Mechanism of resveratrol-mediated suppression of tissue factor gene expression. Thromb Haemost 2002; 87: 155-62.
37. Wadsworth TL, Koop DR. Effects of the wine polyphenolics quercetin and resveratrol on pro-inflammatory cytokine expression in RAW 264.7 macrophages. Biochem Pharmacol 1999; 57: 941-9.
38. Tsai SH, Lin-Shiau SY, Lin JK. Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol. Br J Pharmacol 1999; 126: 673-80.
39. Manna SK, Mukhopadhyay A, Aggarwal BB. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-KB, acti vator protein-1, and apoptosis: potential role of reactive oxygen inter mediates and lipid peroxidation. J Immunol 2000; 164: 6509-19.
40. Mu MM, Chakravortty D, Sugiyama T, Koide N, Takahashi K, Mori I, Yoshida T, Yokochi T. The inhibitory action of quercetin on lipopoly saccharide-induced nitric oxide production in RAW 264.7 macrophage cells. J Endotoxin Res 2001; 7: 431-8.
41. Ishikawa Y, Sugiyama H, Stylianou E, Kitamura M. Bioflavonoid quercetin inhibits interleukin-1-induced transcriptional expression of monocyte chemoattractant protein-1 in glomerular cells via suppression of nuclear factor-kappaB. J Am Soc Nephrol 1999; 10: 2290-6.
42. Rangan GK, Wang Y, Tay YC, Harris DC. Inhibition of NFkappaB activation with antioxidants is correlated with reduced cytokine tran scription in PTC. Am J Physiol 1999; 277: F779-89.
43. Musonda CA, Chipman JK. Quercetin inhibits hydrogen peroxide (H2O2)-induced NF-kappaB DNA binding activity and DNA damage in HepG2 cells. Carcino gene sis 1998; 19: 1583-9.
44. Sato M, Miyazaki T, Kambe F, Maeda K, Seo H. Quercetin, a bio flavonoid, inhibits the induction of interleukin 8 and monocyte che moattractant protein-1 expression by tumor necrosis factor-alpha in cultured human synovial cells. J Rheumatol 1997; 24: 1680-4.
45. Tsai SH, Liang YC, Lin-Shiau SY, Lin JK Suppression of TNFalpha-mediated NFkappaB activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cells. J Cell Biochem 1999; 74: 606-15.
46. Peet GW, Li J. IkappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporine and quercetin. J Biol Chem 1999; 274: 32655-61.
47. Bertelli A, Bertelli AA, Gozzini A, Giovannini L. Plasma and tissue resveratrol concentrations and pharmacological activity. Drugs Exp Clin Res 1998; 24: 133-8.
48. Manach C, Morand V, Crespy V, Demigne C, Texier O, Regerat F, Remesy C. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 1998; 426: 331-6.
49. Hollman PC, van Trijp JM, Buysman MN, van der Gaag MS, Mengelers MJ, de Vries JH, Katan MB. Relative bioavailability of the antioxidant flavonoid quercetin from various food in man. FEBS Lett 1997; 418: 152-6.
50. Bertelli AA, Giovannini L, Stradi R, Urien S, Tillement JP, Bertelli A. Kinetics of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after red wine oral administration in rats. Int J Clin Pharmacol Res 1996; 16: 77-81.
51. Erlich JH, Boyle EM, Labriola J, Kovacich JC, Santucci RA, Fearns C, Morgan EN, Yun W, Luther T, Kojikawa O, Martin TR, Pohlman TH, Verrier ED, Mackman N. Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation. Am J Pathol 2000; 157: 1849-62.
52. Booyse FM, Parks DA. Moderate wine and alcohol consumption: beneficial effects on cardiovascular disease. Thromb Haemost 2001; 86: 517-28.